Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,481
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma

A. Dufresnea Department of Medical Oncology, Centre Léon Bérard, Lyon, FranceCorrespondence[email protected]
View further author information
,
T. Lesluyesb University of Bordeaux, Bordeaux, France;c Inserm U1218, Institut Bergonié, Bordeaux, France;d Inserm UMR1037, Cancer Research Center of Toulouse, Toulouse, France;e Department of Medical Oncology, Institut Claudius Regaud, Toulouse, FranceView further author information
,
C. Ménétrier-Cauxf Inserm U1052, CNRS 5286, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, Bordeaux, FranceView further author information
,
M. Brahmia Department of Medical Oncology, Centre Léon Bérard, Lyon, FranceView further author information
,
E. Darbob University of Bordeaux, Bordeaux, France;c Inserm U1218, Institut Bergonié, Bordeaux, France;g Bordeaux Bioinformatics Center (BCIB), Bordeaux, FranceView further author information
,
M. Toulmondeh Department of Medical Oncology, Institut Bergonié, Bordeaux, FranceView further author information
,
A. Italianoh Department of Medical Oncology, Institut Bergonié, Bordeaux, FranceView further author information
,
O. Miri Department of Ambulatory Care, Institut Gustave Roussy, Villejuif, FranceView further author information
,
A. Le Cesnej Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, FranceView further author information
,
S. Le Guellecd Inserm UMR1037, Cancer Research Center of Toulouse, Toulouse, France;k Department of Pathology, Institut Claudius Regaud, Toulouse, FranceView further author information
,
T. Valentind Inserm UMR1037, Cancer Research Center of Toulouse, Toulouse, France;e Department of Medical Oncology, Institut Claudius Regaud, Toulouse, FranceView further author information
,
C. Chevreaue Department of Medical Oncology, Institut Claudius Regaud, Toulouse, FranceView further author information
,
S. Bonvalotl Department of Surgery, Institut Curie, Bordeaux, FranceView further author information
,
Y.M. Robinm Department of Pathology, Centre Oscar Lambret, Lille, FranceView further author information
,
J-M Coindreb University of Bordeaux, Bordeaux, France;n Department of Pathology, Institut Bergonié, Bordeaux, FranceView further author information
,
C. Cauxf Inserm U1052, CNRS 5286, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, Bordeaux, FranceView further author information
,
J.Y. Blaya Department of Medical Oncology, Centre Léon Bérard, Lyon, France;f Inserm U1052, CNRS 5286, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, Bordeaux, FranceORCID Iconhttps://orcid.org/0000-0001-7190-120XView further author information
ORCID Icon &
F. Chibond Inserm UMR1037, Cancer Research Center of Toulouse, Toulouse, France;e Department of Medical Oncology, Institut Claudius Regaud, Toulouse, FranceView further author information
 show all
Article: 1792036 | Received 17 Dec 2019, Accepted 01 Jul 2020, Published online: 12 Jul 2020

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Candace L. Haddox & Richard F. Riedel. (2023) Emerging predictive biomarkers in the management of bone and soft tissue sarcomas. Expert Review of Anticancer Therapy 23:5, pages 495-502.
Read now
Giacomo G Baldi, Alessandro Gronchi, Marcella Tazzari & Silvia Stacchiotti. (2022) Immunotherapy in soft tissue sarcoma: current evidence and future perspectives in a variegated family of different tumor. Expert Review of Anticancer Therapy 22:5, pages 491-503.
Read now
Arjun Mittra, Naoko Takebe, Vaia Florou, Alice P Chen & Abdul Rafeh Naqash. (2021) The emerging landscape of immune checkpoint inhibitor based clinical trials in adults with advanced rare tumors. Human Vaccines & Immunotherapeutics 17:7, pages 1935-1939.
Read now

Articles from other publishers (25)

Wenting Luo, Youjia Zhou, Jiayang Wang, Keqin Wang, Qing Lin, Yuqiu Li, Yujie Xie, Miao Li, Jie Wang & Lixia Xiong. (2024) YTHDF1’s Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network. International Journal of Molecular Sciences 25:3, pages 1879.
Crossref
Enar Jumaniyazova, Anastasiya Lokhonina, Dzhuliia Dzhalilova, Anna Kosyreva & Timur Fatkhudinov. (2023) Immune Cells in the Tumor Microenvironment of Soft Tissue Sarcomas. Cancers 15:24, pages 5760.
Crossref
Agnieszka E. Zając, Anna M. Czarnecka & Piotr Rutkowski. (2023) The Role of Macrophages in Sarcoma Tumor Microenvironment and Treatment. Cancers 15:21, pages 5294.
Crossref
Jean-Yves Blay, Sylvie Chevret, Axel Le Cesne, Mehdi Brahmi, Nicolas Penel, Sophie Cousin, Francois Bertucci, Emmanuelle Bompas, Thomas Ryckewaert, Pauline Soibinet, Pascaline Boudou-Rouquette, Esma Saada Bouzid, Patrick Soulie, Thibaud Valentin, Jean-Pierre Lotz, Diego Tosi, Zoé Neviere, Mathilde Cancel, Isabelle Ray-Coquard, Laetitia Gambotti, Frédéric Legrand, Assia Lamrani-Ghaouti, Clotilde Simon, Caroline Even & Christophe Massard. (2023) Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial. The Lancet Oncology 24:8, pages 892-902.
Crossref
Xiaolan Feng, Laurie Tonon, Haocheng Li, Elodie Darbo, Erin Pleasance, Nicolas Macagno, Armelle Dufresne, Mehdi Brahmi, Julien Bollard, Francoise Ducimetière, Marie Karanian, Alexandra Meurgey, Gaëlle Pérot, Thibaud Valentin, Frédéric Chibon & Jean-Yves Blay. (2023) Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with “Hot” Tumor Immune Microenvironment. Cancers 15:14, pages 3705.
Crossref
Leilei Li, Wenhui Yang, Daqi Jia, Shiqi Zheng, Yuzhe Gao & Guanghui Wang. (2023) Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation. Breast Cancer 30:4, pages 666-684.
Crossref
Sarah Watson, Nadege Gruel & François Le Loarer. (2023) New developments in the pathology and molecular biology of retroperitoneal sarcomas. European Journal of Surgical Oncology 49:6, pages 1053-1060.
Crossref
Bo Li, Hui Chen, Shaohua Yang, Feng Chen, Liangliang Xu, Yan Li, Mingzhe Li, Chengming Zhu, Fangyuan Shao, Xinhua Zhang, Chuxia Deng, Leli Zeng, Yulong He & Changhua Zhang. (2023) Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers. Molecular Cancer 22:1.
Crossref
Ali Tayebi, Faranak Olamaeian, Arash Pour Mohammad, Milad Gholizadeh Mesgarha, Leila Asef-Kabiri, Farid Moradian, Behrad Seyedesfahani & Mohammad Esmaeil Akbari. (2023) Epidemiological Study of Hepatopancreatobiliary Sarcoma in Iran, 2010 - 2014. International Journal of Cancer Management 15:12.
Crossref
Rossana Lazcano, Carmelia M. Barreto, Ruth Salazar, Fernando Carapeto, Raymond S. Traweek, Cheuk H. Leung, Swati Gite, Jay Mehta, Davis R. Ingram, Khalida M. Wani, Kim-Anh T. Vu, Edwin R. Parra, Wei Lu, Jianling Zhou, Russell G. Witt, Brandon Cope, Prapassorn Thirasastr, Heather Y. Lin, Christopher P. Scally, Anthony P. Conley, Ravin Ratan, J. Andrew Livingston, Alexandra M. Zarzour, Joseph Ludwig, Dejka Araujo, Vinod Ravi, Shreyaskumar Patel, Robert Benjamin, Jennifer Wargo, Ignacio I. Wistuba, Neeta Somaiah, Christina L. Roland, Emily Z. Keung, Luisa Solis, Wei-Lien Wang, Alexander J. Lazar & Elise F. Nassif. (2022) The immune landscape of undifferentiated pleomorphic sarcoma. Frontiers in Oncology 12.
Crossref
Antonia Resag, Giulia Toffanin, Iva Benešová, Luise Müller, Vlatko Potkrajcic, Andrej Ozaniak, Robert Lischke, Jirina Bartunkova, Antonio Rosato, Korinna Jöhrens, Franziska Eckert, Zuzana Strizova & Marc Schmitz. (2022) The Immune Contexture of Liposarcoma and Its Clinical Implications. Cancers 14:19, pages 4578.
Crossref
Amani Arthur, Edward W. Johnston, Jessica M. Winfield, Matthew D. Blackledge, Robin L. Jones, Paul H. Huang & Christina Messiou. (2022) Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?. Frontiers in Oncology 12.
Crossref
Cristiam Moreno Tellez, Yan Leyfman, Sandra P. D'Angelo, Breelyn A. Wilky & Armelle Dufresne. (2022) Immunotherapy in Sarcoma. Surgical Oncology Clinics of North America 31:3, pages 381-397.
Crossref
Peter H. Goff, Laura Riolobos, Bonnie J. LaFleur, Matthew B. Spraker, Y. David Seo, Kimberly S. Smythe, Jean S. Campbell, Robert H. Pierce, Yuzheng ZhangQianchuan HeEdward Y. Kim, Stephanie K. Schaub, Gabrielle M. Kane, Jose G. Mantilla, Eleanor Y. Chen, Robert Ricciotti, Matthew J. Thompson, Lee D. CranmerMichael J. WagnerElizabeth T. Loggers, Robin L. Jones, Erin MurphyWendy M. BlumenscheinTerrill K. McClanahanJon EarlsKevin C. FlanaganNatalie A. LaFranzoTeresa S. Kim & Seth M. Pollack. (2022) Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells. Clinical Cancer Research 28:8, pages 1701-1711.
Crossref
Alexandre de Nonneville, Pascal Finetti, Maelle Picard, Audrey Monneur, Maria Abbondanza Pantaleo, Annalisa Astolfi, Jerzy Ostrowski, Daniel Birnbaum, Emilie Mamessier & François Bertucci. (2022) CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response. Cancers 14:5, pages 1306.
Crossref
Markus Albertsmeier, Annelore Altendorf-Hofmann, Lars H. Lindner, Rolf D. Issels, Eric Kampmann, Hans-Roland Dürr, Martin K. Angele, Frederick Klauschen, Jens Werner, Achim A. Jungbluth & Thomas Knösel. (2022) VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?. Cancers 14:4, pages 1006.
Crossref
Francois Bertucci, Vincent Niziers, Alexandre de Nonneville, Pascal Finetti, Léna Mescam, Olivier Mir, Antoine Italiano, Axel Le Cesne, Jean-Yves Blay, Michele Ceccarelli, Davide Bedognetti, Daniel Birnbaum & Emilie Mamessier. (2022) Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. Journal for ImmunoTherapy of Cancer 10:1, pages e003687.
Crossref
Matthieu Roulleaux Dugage, Elise F. Nassif, Antoine Italiano & Rastislav Bahleda. (2021) Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review. Frontiers in Immunology 12.
Crossref
Dalong Wei, Xiaoling Lan, Zhiqun Huang, Qiang Tang, Zechen Wang, Yanfei Ma, Liuzhi Wei, Qiuju Wei, Jingjie Zhao, Jiajia Shen, Siyuan He, Jian Song, Lingzhang Meng & Qianli Tang. (2021) Pyroptosis-Related Gene Signature Is a Novel Prognostic Biomarker for Sarcoma Patients. Disease Markers 2021, pages 1-13.
Crossref
Malte Simon, Sadaf S. Mughal, Peter Horak, Sebastian Uhrig, Jonas Buchloh, Bogac Aybey, Albrecht Stenzinger, Hanno Glimm, Stefan Fröhling, Benedikt Brors & Charles D. Imbusch. (2021) Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations. Journal of Translational Medicine 19:1.
Crossref
Fan Tang, Yan Tie, Yu-Quan Wei, Chong-Qi Tu & Xia-Wei Wei. (2021) Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188606.
Crossref
Matthieu Roulleaux Dugage, Robin Lewis Jones, Jonathan Trent, Stéphane Champiat & Sarah Dumont. (2021) Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors. Frontiers in Immunology 12.
Crossref
Luana Madalena Sousa, Jani Sofia Almeida, Tânia Fortes-Andrade, Manuel Santos-Rosa, Paulo Freitas-Tavares, José Manuel Casanova & Paulo Rodrigues-Santos. (2021) Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy. Cancers 13:15, pages 3885.
Crossref
Michael Saerens, Nele Brusselaers, Sylvie Rottey, Alexander Decruyenaere, David Creytens & Lore Lapeire. (2021) Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis. European Journal of Cancer 152, pages 165-182.
Crossref
Hui Yi Chew, Victor Chan, Fiona Simpson & Riccardo Dolcetti. (2020) Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?. Cancers 12:11, pages 3392.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.